The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
still not appearing on uk clinical trials list... frustrating
Back as chief business officer according to his linkedin. I like the guy but know that others didn't...
I've got NAV at approx $260M
Massively oversold imo but that's crypto isn't it. It's definitely a loading opportunity though with large NAV increases coming very shortly with ACALA, Moonbeam and ASTAR going live though.
On 2nd Dec which we are presenting at... first in a while.
Is there a vid or audio recording of the agm?
No more chunky delayed trades, might mean that sellers are done leaving us set for a rise. I do worry though that alot of the long term holders are already overweight in KR1 so not willing to add substantially more. We need FTI to pull their fingers out and spread the word!
My top up from earlier this afternoon not showing yet. The lack of KR1 PR around the parachains is painful. Total silence around the biggest inflection point the company is going to have for a while (possibly ever). What on earth are FTI up to. They've added precisely zero value.
Not necessarily a bad thing for people to be making money directly in sh*t coins. The profits have a tendency to make their way back here. We've traded over NAV in the past, so trading under NAV for a bit isn't the end of the world. That said it is astonishing that there are sellers around with KR1 poised to invest up to $150M in parachain auctions. If KSM is anything to go by there are going to be some serious returns on these investments (between 5x and 15x or more). Just in case anyone can't do maths 15 x $150 Million is a F**k load!! Good weekend everyone!